SU, Hong-Lin,LIN, Shinn-Zong,HARN, Horng-Jyh,CHIOU, Tzyy-Wen,CHUANG, Hong-Meng
申请号：
EP17798677
公开号：
EP3459539A4
申请日:
2017.05.12
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
An application using an active ingredient for preparing a pharmaceutical formulation. The pharmaceutical formulation is used for delaying the incidence and/or treatment of a pulmonary fibrosis. The active ingredient is selected from the following groups: a compound represented by formula (I), a pharmaceutically acceptable salt thereof, or a combination of the compound and the salt, wherein A is a five-carbon alkyl or alkenyl group comprising substituents listed in the following as required: -OH and =O； X is H or OH； Y is O； and if R1 is H or does not exist, then Y and A can form a bond to form a five-membered ring.
